Work

Preliminary efficacy and safety of first-line anlotinib plus carboplatin/paclitaxel induction therapy followed by anlotinib maintenance in advanced ovarian cancer: Results from the ALTER-GO-010 phase II multicenter trial.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.5576

Authors: Wenjun Cheng, Yi Jiang, Yingchun Gao, Youguo Chen, Yulang Cai, Huaijun Zhou, Jinjin Yu, Jinhua Zhou

Institutions: Jiangsu Province Hospital, Huaian First People’s Hospital, First Affiliated Hospital of Soochow University, Zhongda Hospital Southeast University, Nanjing Drum Tower Hospital, Jiangnan University, Wuxi Fourth People's Hospital

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162492825

Cites:

Cited by:

Related to: